Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Hepatology
Volume 2016 (2016), Article ID 4356749, 3 pages
http://dx.doi.org/10.1155/2016/4356749
Case Report

Acute Hepatitis after Ingestion of a Preparation of Chinese Skullcap and Black Catechu for Joint Pain

1Department of Gastroenterology, Hepatology and Nutrition, MD Anderson Cancer Center, Houston, TX 77030, USA
2Department of Gastroenterology & Hepatology, The Brooklyn Hospital Center, Brooklyn, NY 11201, USA

Received 9 December 2015; Accepted 21 March 2016

Academic Editor: Mario Pirisi

Copyright © 2016 Charilaos Papafragkakis et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. I. Jang, H. J. Kim, K. M. Hwang et al., “Hepatoprotective effect of baicalin, a major flavone form Scutellaria radix, on acetaminophen-induced liver injury in mice,” Immunopharmacology and Immunotoxicology, vol. 25, pp. 585–594, 2003. View at Google Scholar
  2. R. Awad, J. T. Arnason, V. Trudeau et al., “Phytochemical and biological analysis of Skullcap (Scutellaria lateriflora L.): a medicinal plant with anxiolytic properties,” Phytomedicine, vol. 10, no. 8, pp. 640–649, 2003. View at Publisher · View at Google Scholar · View at Scopus
  3. Y.-C. Shen, W.-F. Chiou, Y.-C. Chou, and C.-F. Chen, “Mechanisms in mediating the anti-inflammatory effects of baicalin and baicalein in human leukocytes,” European Journal of Pharmacology, vol. 465, no. 1-2, pp. 171–181, 2003. View at Publisher · View at Google Scholar · View at Scopus
  4. Y. Huang, S.-Y. Tsang, X. Yao, and Z.-Y. Chen, “Biological properties of baicalein in cardiovascular system,” Current Drug Target—Cardiovascular & Hematological Disorders, vol. 5, no. 2, pp. 177–184, 2005. View at Publisher · View at Google Scholar
  5. M. Bonham, J. Posakony, I. Coleman, B. Montgomery, J. Simon, and P. S. Nelson, “Characterization of chemical constituents in Scutellaria baicalensis with antiandrogenic and growth-inhibitory activities toward prostate carcinoma,” Clinical Cancer Research, vol. 11, no. 10, pp. 3905–3914, 2005. View at Publisher · View at Google Scholar · View at Scopus
  6. M.-Y. Lai, S.-L. Hsiu, Y.-C. Hou, S.-Y. Tsai, and P.-D. L. Chao, “Significant decrease of cyclosporine bioavailability in rats caused by a decoction of the roots of Scutellaria baicalensis,” Planta Medica, vol. 70, no. 2, pp. 132–137, 2004. View at Publisher · View at Google Scholar · View at Scopus
  7. L. Fan, W. Zhang, D. Guo et al., “The effect of herbal medicine baicalin on pharmacokinetics of rosuvastatin, substrate of organic anion-transporting polypeptide 1B1,” Clinical Pharmacology and Therapeutics, vol. 83, no. 3, pp. 471–476, 2008. View at Publisher · View at Google Scholar · View at Scopus
  8. T. Kiguchi, F. Kimura, K. Niiya, Y. Katayama, and M. Harada, “Acute thrombocytopenic purpura after ingestion of Sho-saiko-to for hepatitis,” Liver, vol. 20, no. 6, p. 491, 2000. View at Publisher · View at Google Scholar · View at Scopus
  9. K. Takeshita, Y. Saisho, K. Kitamura et al., “Pneumonitis induced by ou-gon (scullcap),” Internal Medicine, vol. 40, no. 8, pp. 764–768, 2001. View at Publisher · View at Google Scholar · View at Scopus
  10. R. Dhanasekaran, V. Owens, and W. Sanchez, “Chinese skullcap in move free arthritis supplement causes drug induced liver injury and pulmonary infiltrates,” Case Reports in Hepatology, vol. 2013, Article ID 965092, 4 pages, 2013. View at Publisher · View at Google Scholar
  11. L.-M. Hsu, Y.-S. Huang, S.-H. Tsay, F.-Y. Chang, and S.-D. Lee, “Acute hepatitis induced by Chinese hepatoprotective herb, xiao-chai-hu-tang,” Journal of the Chinese Medical Association, vol. 69, no. 2, pp. 86–88, 2006. View at Publisher · View at Google Scholar · View at Scopus
  12. S. Itoh, K. Marutani, T. Nishijima, S. Matsuo, and M. Itabashi, “Liver injuries induced by herbal medicine, Syo-saiko-to (xiao-chai-hu-tang),” Digestive Diseases and Sciences, vol. 40, no. 8, pp. 1845–1848, 1995. View at Publisher · View at Google Scholar · View at Scopus
  13. L. Yang, A. Aronsohn, J. Hart, and D. Jensen, “Herbal hepatoxicity from Chinese skullcap: a case report,” World Journal of Hepatology, vol. 4, no. 7, pp. 231–233, 2012. View at Publisher · View at Google Scholar · View at Scopus
  14. S. A. Linnebur, O. C. Rapacchietta, and M. Vejar, “Hepatotoxicity associated with Chinese skullcap contained in move free advanced dietary supplement: two case reports and review of the literature,” Pharmacotherapy, vol. 30, no. 7, pp. 258e–262e, 2010. View at Google Scholar · View at Scopus
  15. P. Jayasekhar, P. V. Mohanan, and K. Rathinam, “Hepatoprotective activity of ethyl acetate extract of Acacia catechu,” Indian Journal of Pharmacology, vol. 29, no. 6, pp. 426–428, 1997. View at Google Scholar · View at Scopus
  16. R. Teschke, L. Zhang, H. Long et al., “Traditional Chinese medicine and herbal hepatotoxicity: a tabular compilation of reported cases,” Annals of Hepatology, vol. 14, no. 1, pp. 7–19, 2015. View at Google Scholar · View at Scopus
  17. R. Teschke and A. Eickhoff, “Herbal hepatotoxicity in traditional and modern medicine: actual key issues and new encouraging steps,” Frontiers in Pharmacology, vol. 6, article 72, 2015. View at Publisher · View at Google Scholar · View at Scopus
  18. G. Danan and R. Teschke, “RUCAM in drug and herb induced liver injury: the update,” International Journal of Molecular Sciences, vol. 17, no. 1, p. 14, 2016. View at Publisher · View at Google Scholar
  19. U.S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER), and Center for Biologics Evaluation and Research (CBER), “Guidance for industry drug induced liver injury: pre-marketing clinical evaluation,” 2009, http://www.fda.gov/downloads/Drugs/%E2%80%A6/Guidances/UCM174090.pdf.